Loading
Latest filing published 20 May 2026 for LifeTech Scientific Corporation.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Feng Xiaoling in LifeTech Scientific Corporation, where the filings describe the role as chief executive. Over a trading history stretching from 21 November 2025 to 15 May 2026, the count stands at 4 filings.
On the open market, the record shows 1 purchase and 1 sale. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 1 purchase and 1 sale.
On 20 May 2026 came the latest disclosure, a transaction in LifeTech Scientific Corporation. The clock since the last published purchase (12 May 2026) now reads 165 days. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations